These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 1620118

  • 1. The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.
    Kumar S, Rabson AB, Gélinas C.
    Mol Cell Biol; 1992 Jul; 12(7):3094-106. PubMed ID: 1620118
    [Abstract] [Full Text] [Related]

  • 2. I kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motif.
    Kumar S, Gélinas C.
    Proc Natl Acad Sci U S A; 1993 Oct 01; 90(19):8962-6. PubMed ID: 8415639
    [Abstract] [Full Text] [Related]

  • 3. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH, Stein B, Ganchi PA, Hoffman JA, Kaufman PA, Ballard DW, Hannink M, Greene WC.
    J Virol; 1992 Aug 01; 66(8):5018-29. PubMed ID: 1321284
    [Abstract] [Full Text] [Related]

  • 4. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S, Capobianco AJ, Gilmore TD.
    Oncogene; 1993 Sep 01; 8(9):2501-9. PubMed ID: 8361761
    [Abstract] [Full Text] [Related]

  • 5. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW, Pitoc GA, Gilmore TD.
    Mol Cell Biol; 1996 Mar 01; 16(3):1169-78. PubMed ID: 8622661
    [Abstract] [Full Text] [Related]

  • 6. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
    Diehl JA, McKinsey TA, Hannink M.
    Mol Cell Biol; 1993 Mar 01; 13(3):1769-78. PubMed ID: 8441412
    [Abstract] [Full Text] [Related]

  • 7. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G, Gilmore TD.
    Oncogene; 1993 Mar 01; 8(3):721-30. PubMed ID: 8437855
    [Abstract] [Full Text] [Related]

  • 8. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE, Boehmelt G, Enrietto PJ.
    Oncogene; 1992 Jun 01; 7(6):1137-47. PubMed ID: 1594245
    [Abstract] [Full Text] [Related]

  • 9. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Ballard DW, Walker WH, Doerre S, Sista P, Molitor JA, Dixon EP, Peffer NJ, Hannink M, Greene WC.
    Cell; 1990 Nov 16; 63(4):803-14. PubMed ID: 2225078
    [Abstract] [Full Text] [Related]

  • 10. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J, Schatzle JD, Liss AS, Bargmann W, Bose HR.
    Oncogene; 1996 Jun 20; 12(12):2595-604. PubMed ID: 8700518
    [Abstract] [Full Text] [Related]

  • 11. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
    Mosialos G, Hamer P, Capobianco AJ, Laursen RA, Gilmore TD.
    Mol Cell Biol; 1991 Dec 20; 11(12):5867-77. PubMed ID: 1944267
    [Abstract] [Full Text] [Related]

  • 12. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
    Diehl JA, Hannink M.
    J Virol; 1993 Dec 20; 67(12):7161-71. PubMed ID: 8230438
    [Abstract] [Full Text] [Related]

  • 13. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R, Nehyba J, Bose HR.
    J Virol; 1995 Jun 20; 69(6):3369-80. PubMed ID: 7745683
    [Abstract] [Full Text] [Related]

  • 14. Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.
    Chen C, Agnès F, Gélinas C.
    Mol Cell Biol; 1999 Jan 20; 19(1):307-16. PubMed ID: 9858554
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
    La Rosa FA, Pierce JW, Sonenshein GE.
    Mol Cell Biol; 1994 Feb 20; 14(2):1039-44. PubMed ID: 8289784
    [Abstract] [Full Text] [Related]

  • 16. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J, Brent R.
    New Biol; 1991 Oct 20; 3(10):1005-13. PubMed ID: 1768648
    [Abstract] [Full Text] [Related]

  • 17. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
    Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R.
    Mol Cell Biol; 1992 Feb 20; 12(2):674-84. PubMed ID: 1732739
    [Abstract] [Full Text] [Related]

  • 18. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
    Kabrun N, Hodgson JW, Doemer M, Mak G, Franza BR, Enrietto PJ.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1783-7. PubMed ID: 1848011
    [Abstract] [Full Text] [Related]

  • 19. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.
    Ishikawa H, Asano M, Kanda T, Kumar S, Gélinas C, Ito Y.
    Oncogene; 1993 Nov 01; 8(11):2889-96. PubMed ID: 8414493
    [Abstract] [Full Text] [Related]

  • 20. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD, Kralova J, Bose HR.
    J Virol; 1995 Sep 01; 69(9):5383-90. PubMed ID: 7636983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.